FDA WARNING_LETTER - mahita, llc - August 16, 2021

On August 19, 2021, the FDA and FTC issued a Warning Letter to PushMyCart regarding the sale of unapproved and misbranded products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19. The agencies reviewed the company's website (https://www.pushmycart.com), Facebook page (https://www.facebook.com/pushmycartglobal), and Amazon storefront (PushMyCart) on August 2 and 16, 2021.

The products cited include "Patanjali Coronil Kit," "Dr. Reckeweg Arsenic Album Dilution 30 CH," "SBL Arsenicum Album Dilution 30 CH," "Kerala Ayurveda Balarishtam," and "Kottakkal Balarishtam." The FDA determined these are unapproved new drugs, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)).

Examples of violative claims include "PATANJALI Corona KIT," "coronapre